A New Tool to Predict Survival after Radiosurgery Alone for Newly Diagnosed Cerebral Metastases |
Rades, Dirk
(Department of Radiation Oncology, Faculty of Medicine, University of Lubeck)
Huttenlocher, Stefan (Department of Radiation Oncology, Faculty of Medicine, University of Lubeck) Dziggel, Liesa (Department of Radiation Oncology, Faculty of Medicine, University of Lubeck) Blanck, Oliver (Department of Radiosurgery, CyberKnife Centre Northern Germany) Hornung, Dagmar (Department of Radiation Oncology, Faculty of Medicine, University of Hamburg) Mai, Khoa Trong (Department of Nuclear Medicine, Faculty of Medicine Hanoi Medical University) Ngo, Trang Thuy (Department of Radiation Oncology, Nuclear Medicine and Oncology Center, Bach Mai Hospital) Pham, Thai Van (Department of Radiation Oncology, Nuclear Medicine and Oncology Center, Bach Mai Hospital) Schild, Steven (Department of Radiation Oncology, Mayo Clinic Scottsdale) |
1 | Akhavan A, Binesh F, Heidari S (2014). Survival of brain metastatic patients in Yazd, Iran. Asian Pac J Cancer Prev, 15, 3571-4. DOI |
2 | Brown PD, Pugh S, Laack NN, et al (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol, 15, 1429-37. DOI ScienceOn |
3 | Chindaprasirt J, Sookprasert A, Sawanyawisuth K, Limpawattana P, Tiamkao S (2012). Brain metastases from cholangiocarcinoma: a first case series in Thailand. Asian Pac J Cancer Prev, 13, 1995-7. DOI |
4 | DeAngelis LM, Delattre JY, Posner JB (1989). Radiationinduced dementia in patients cured of brain metastases. Neurology, 39, 789-96. DOI |
5 | Demircioglu F, Demirci U, Akmansu M (2013). Lymph node ratio assessment of brain metastasis in early breast cancer cases. Asian Pac J Cancer Prev, 14, 1665-7. DOI |
6 | Duan L, Zeng R, Yang KH, et al (2014). Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastases: a meta-analysis. Asian Pac J Cancer Prev, 15, 911-5. DOI ScienceOn |
7 | Dziggel L, Segedin B, Podvrsnik NH, et al (2013). Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol, 189, 364-6. DOI |
8 | Erten C, Demir L, Somali I, et al (2013). Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? Asian Pac J Cancer Prev, 14, 3711-7. DOI |
9 | Hyun MK, Hwang JS, Kim JH, et al (2013). Survival outcomes after whole brain radiation therapy and/or stereotactic radiosurgery for cancer patients with metastatic brain tumors in Korea: a systematic review. Asian Pac J Cancer Prev, 14, 7401-7. DOI ScienceOn |
10 | Inamoto T, Azuma H, Nonomura N, et al (2014). Favorable outcome in elderly Asian patients with metastatic renal cell carcinoma treated with everolimus: the Osaka urologic oncology group. Asian Pac J Cancer Prev, 15, 1811-5. DOI |
11 | Rades D, Panzner A, Dziggel L, et al (2012). Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer, 118, 3852-9. DOI |
12 | Liu WJ, Zeng XT, Qin HF, et al (2012). Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: a meta-analysis of 19 randomized controlled trials. Asian Pac J Cancer Prev, 13, 3253-8. DOI ScienceOn |
13 | Lorenzoni J, Devriendt D, Massager N, et al (2004). Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys, 60, 218-24. DOI |
14 | Mutlu H, Buyukcelik A, Erden A, et al (2013). Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival. Asian Pac J Cancer Prev, 14, 3743-6. DOI ScienceOn |
15 | Rades D, Dziggel L, Nagy V, et al (2013). A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone. Radiother Oncol, 108, 123-7. DOI |
16 | Sun DS, Hu LK, Cai Y, et al (2014). A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 1233-9. DOI ScienceOn |
17 | Vuong DA, Rades D, Le AN, Busse R (2012). The costeffectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families. World Neurosurg, 77, 321-8. DOI |
18 | Vuong DA, Rades D, van Eck AT, Horstmann GA, Busse R (2013). Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection. Clin Neurol Neurosurg, 115, 276-84. DOI |
19 | Yamamoto M, Sato Y, Serizawa T, et al (2012). Subclassification of recursive partitioning analysis class II patients with brain metastases treated radiosurgically. Int J Radiat Oncol Biol Phys, 83, 1399-1405. DOI |
20 | Weltman E, Salvajoli JV, Brandt RA, et al (2000). Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys, 46, 1155-61. DOI |
21 | Zeng YD, Zhang L, Liao H, et al (2012). Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study. Asian Pac J Cancer Prev, 13, 909-14. DOI ScienceOn |
22 | Zhang JH, Wang MS, Pan HH, et al (2012). Correlation of CT perfusion images with VEGF expression in solitary brain metastases. Asian Pac J Cancer Prev, 13, 1575-8. DOI |
![]() |